Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC-RT for Locally-advanced Cervical Cancer
NCT06529809Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2025
- Primary completion
- Dec 2031
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Cervical Cancer (CC), sponsored by Washington University School of Medicine. Primary endpoint: Late treatment related grade 3 or greater gastrointestinal and genitourinary adverse events. Started Feb 2025; status: recruiting.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT06529809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06529809.